ElectroCore
$9.99
40
+$1.01+11.25% 今天
統計
當日最高
10.2
當日最低
9.25
52週最高
10.2
52週最低
5.02
成交量
204,369
平均成交量
21,103
市值
39M
市盈率
-
股息收益率
-
股息
-
即將到來
收益
14Nov預期
預期每股收益
-0.305
實際每股收益
N/A
人們還關注
此列表基於在 Stock Events 上關注 ECOR 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
Axonics
AXNX
市值3.54B
LivaNova
LIVN
市值2.74B
Inspire Medical Systems
INSP
市值5.36B
Neogen
NEOG
市值3.74B
Boston Scientific
BSX
市值120.45B
Abbvie
ABBV
市值346.75B
Medtronic
MDT
市值113.61B
Smith & Nephew
SNN
市值13.45B
Stryker
SYK
市值137.35B
關於
Health Technology
Medical Specialties
Manufacturing
Electromedical and Electrotherapeutic Apparatus Manufacturing
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Show more...
首席執行官
員工
68
國家
US
ISIN
US28531P1030